Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arexvy
Pharma
GSK touts co-administration data for RSV, shingles vaccines
GSK's RSV vax and shingles jab elicited non-inferior immune responses when given during the same doctor's visit compared with separate administration.
Zoey Becker
Sep 18, 2024 11:22am
GSK cuts 2024 vaccines sales amid CDC's narrowed RSV policy
Jul 31, 2024 10:13am
UK selects Pfizer over GSK to supply RSV vaccines for 2 years
Jun 24, 2024 11:19am
GSK's Arexvy has expanded its label into adults ages 50-59
Jun 7, 2024 6:45pm
GSK's Arexvy dominates RSV market ahead of new competition
May 1, 2024 11:20am
Pfizer plots new RSV filing with positive Abrysvo data in adults
Apr 9, 2024 6:45am
